Beech Hill Advisors’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-32,944
Closed -$2.9M 109
2015
Q2
$2.9M Sell
32,944
-2,037
-6% -$187K 1.49% 28
2015
Q1
$3.09M Sell
34,981
-368
-1% -$32.6K 1.45% 28
2014
Q4
$2.94M Buy
35,349
+167
+0.5% +$13.8K 1.46% 27
2014
Q3
$2.97M Sell
35,182
-24,412
-41% -$1.98M 1.4% 31
2014
Q2
$4.83M Sell
59,594
-1,926
-3% -$151K 2.13% 15
2014
Q1
$4.69M Buy
61,520
+419
+0.7% +$30.5K 2.2% 16
2013
Q4
$4.4M Sell
61,101
-725
-1% -$50.4K 2.22% 17
2013
Q3
$4.25M Sell
61,826
-475
-0.8% -$31.4K 2.3% 13
2013
Q2
$3.95M Buy
+62,301
New +$4.05M 2.23% 17

Other funds holding NVS

Beech Hill Advisors's NVS Position: Q3 2015 in Review

Beech Hill Advisors sold out of Novartis (NVS) in Q3 2015, closing a stake of 32,944 shares — an estimated $2.9M sold.

Beech Hill Advisors first reported a position in NVS in Q2 2013 and held it in 9 quarters. The position peaked at $4.83M in Q2 2014. 926 funds tracked by Wall St. Rank hold NVS as of Q3 2015.

  • Beech Hill Advisors reported no remaining Novartis position as of Q3 2015 after selling out during the quarter.
  • Beech Hill Advisors sold 32,944 Novartis shares in Q3 2015, an estimated $2.9M.
  • Beech Hill Advisors first reported a position in Novartis in Q2 2013 and held it in 9 quarters.
  • Beech Hill Advisors's Novartis position peaked at $4.83M in Q2 2014.
  • 926 funds tracked by Wall St. Rank held Novartis as of Q3 2015.

Based on Beech Hill Advisors's 13F filing for Q3 2015, filed 30 Oct 2015.